378 related articles for article (PubMed ID: 30862050)
21. GSK-3α/β and MEK inhibitors assist the microenvironment of tumor initiation.
Hassan G; Afify SM; Zahra MH; Nawara HM; Kumon K; Iwasaki Y; Salomon DS; Seno A; Seno M
Cytotechnology; 2023 Jun; 75(3):243-253. PubMed ID: 37181678
[TBL] [Abstract][Full Text] [Related]
22. Cancer stem cell niche: the place to be.
Borovski T; De Sousa E Melo F; Vermeulen L; Medema JP
Cancer Res; 2011 Feb; 71(3):634-9. PubMed ID: 21266356
[TBL] [Abstract][Full Text] [Related]
23. Cancer stem cells (CSCs) in cancer progression and therapy.
Najafi M; Farhood B; Mortezaee K
J Cell Physiol; 2019 Jun; 234(6):8381-8395. PubMed ID: 30417375
[TBL] [Abstract][Full Text] [Related]
24. Role of Microenvironment on the Fate of Disseminating Cancer Stem Cells.
Ingangi V; Minopoli M; Ragone C; Motti ML; Carriero MV
Front Oncol; 2019; 9():82. PubMed ID: 30847298
[TBL] [Abstract][Full Text] [Related]
25. Vascular determinants of cancer stem cell dormancy--do age and coagulation system play a role?
Rak J; Milsom C; Yu J
APMIS; 2008; 116(7-8):660-76. PubMed ID: 18834410
[TBL] [Abstract][Full Text] [Related]
26. Cancer stem cells: progress and challenges in lung cancer.
Templeton AK; Miyamoto S; Babu A; Munshi A; Ramesh R
Stem Cell Investig; 2014; 1():9. PubMed ID: 27358855
[TBL] [Abstract][Full Text] [Related]
27. Concise Review: Targeting Cancer Stem Cells Using Immunologic Approaches.
Pan Q; Li Q; Liu S; Ning N; Zhang X; Xu Y; Chang AE; Wicha MS
Stem Cells; 2015 Jul; 33(7):2085-92. PubMed ID: 25873269
[TBL] [Abstract][Full Text] [Related]
28. MEK1/2 is a bottleneck that induces cancer stem cells to activate the PI3K/AKT pathway.
Hassan G; Afify SM; Du J; Nawara HM; Sheta M; Monzur S; Zahra MH; Abu Quora HA; Mansour H; El-Ghlban S; Uesaki R; Seno A; Seno M
Biochem Biophys Res Commun; 2021 Oct; 583():49-55. PubMed ID: 34735879
[TBL] [Abstract][Full Text] [Related]
29. The CXCL12 Crossroads in Cancer Stem Cells and Their Niche.
López-Gil JC; Martin-Hijano L; Hermann PC; Sainz B
Cancers (Basel); 2021 Jan; 13(3):. PubMed ID: 33530455
[TBL] [Abstract][Full Text] [Related]
30. Cancer stem cells and tumor heterogeneity: Deciphering the role in tumor progression and metastasis.
Kapoor-Narula U; Lenka N
Cytokine; 2022 Sep; 157():155968. PubMed ID: 35872504
[TBL] [Abstract][Full Text] [Related]
31. Colorectal cancer stem cells.
Vaiopoulos AG; Kostakis ID; Koutsilieris M; Papavassiliou AG
Stem Cells; 2012 Mar; 30(3):363-71. PubMed ID: 22232074
[TBL] [Abstract][Full Text] [Related]
32. Nuclear reprogramming of luminal-like breast cancer cells generates Sox2-overexpressing cancer stem-like cellular states harboring transcriptional activation of the mTOR pathway.
Corominas-Faja B; Cufí S; Oliveras-Ferraros C; Cuyàs E; López-Bonet E; Lupu R; Alarcón T; Vellon L; Iglesias JM; Leis O; Martín ÁG; Vazquez-Martin A; Menendez JA
Cell Cycle; 2013 Sep; 12(18):3109-24. PubMed ID: 23974095
[TBL] [Abstract][Full Text] [Related]
33. Nanomedicine strategies for sustained, controlled, and targeted treatment of cancer stem cells of the digestive system.
Xie FY; Xu WH; Yin C; Zhang GQ; Zhong YQ; Gao J
World J Gastrointest Oncol; 2016 Oct; 8(10):735-744. PubMed ID: 27795813
[TBL] [Abstract][Full Text] [Related]
34. Cancer stem cells and the tumor microenvironment: interplay in tumor heterogeneity.
Albini A; Bruno A; Gallo C; Pajardi G; Noonan DM; Dallaglio K
Connect Tissue Res; 2015; 56(5):414-25. PubMed ID: 26291921
[TBL] [Abstract][Full Text] [Related]
35. Evolving Strategies for Therapeutically Targeting Cancer Stem Cells.
Talukdar S; Emdad L; Das SK; Sarkar D; Fisher PB
Adv Cancer Res; 2016; 131():159-91. PubMed ID: 27451127
[TBL] [Abstract][Full Text] [Related]
36. CSC Radioresistance: A Therapeutic Challenge to Improve Radiotherapy Effectiveness in Cancer.
Olivares-Urbano MA; Griñán-Lisón C; Marchal JA; Núñez MI
Cells; 2020 Jul; 9(7):. PubMed ID: 32660072
[TBL] [Abstract][Full Text] [Related]
37. Cancer stem cell niche models and contribution by mesenchymal stroma/stem cells.
Melzer C; von der Ohe J; Lehnert H; Ungefroren H; Hass R
Mol Cancer; 2017 Feb; 16(1):28. PubMed ID: 28148265
[TBL] [Abstract][Full Text] [Related]
38. A cancer stem cell model as the point of origin of cancer-associated fibroblasts in tumor microenvironment.
Nair N; Calle AS; Zahra MH; Prieto-Vila M; Oo AKK; Hurley L; Vaidyanath A; Seno A; Masuda J; Iwasaki Y; Tanaka H; Kasai T; Seno M
Sci Rep; 2017 Jul; 7(1):6838. PubMed ID: 28754894
[TBL] [Abstract][Full Text] [Related]
39. Engineered extracellular microenvironment with a tunable mechanical property for controlling cell behavior and cardiomyogenic fate of cardiac stem cells.
Choi MY; Kim JT; Lee WJ; Lee Y; Park KM; Yang YI; Park KD
Acta Biomater; 2017 Mar; 50():234-248. PubMed ID: 28063988
[TBL] [Abstract][Full Text] [Related]
40. Cancer stem cell, niche and EGFR decide tumor development and treatment response: A bio-computational simulation study.
Zhu X; Zhou X; Lewis MT; Xia L; Wong S
J Theor Biol; 2011 Jan; 269(1):138-49. PubMed ID: 20969880
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
